Tofacitinib

Tofacitinib · JAK1/JAK3 inhibitor

Rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, ankylosing spondylitis

5mg tablets Twice daily oral Insurance Category B

Therapeutic Areas

Anti-Inflammatory

Marketed Products

Tofacitinib

Modality

Tofacitinib

Core Products

Adalimumab · Fully human anti-TNF-α monoclonal antibody

Baricitinib · Selective JAK1/JAK2 inhibitor

Creating a Healthier Future Together

Explore our innovative products and pipeline, and see how Poseidon brings hope to patients worldwide